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Although altered T cell function takes part in immunosenescence, the mechanisms 
remain uncertain. Here we identify a bona fide age-dependent PD-1+ memory 
phenotype (MP) CD4+ T cell subpopulation, which hardly proliferates in response 
to TCR-stimulation and produces abundant osteopontin at the cost of typical T-cell 
lymphokines. These T cells show an impaired repopulation in Rag2-/- mice, 
whereas a homeostatic proliferation in γ-ray irradiated mice is retained. These T 
cells also reveal a unique molecular signature, including a strong expression of 
C/EBPα  normally expressed in myeloid-lineage cells with diminished c-Myc and 
Cyclin D1. Transduction of Cebpa in regular CD4+ T cells inhibited the 
TCR-mediated proliferation with c-Myc and Cyclin D1 repression and caused a 
striking activation of Spp1encoding osteopontin with concomitant repression of 
T-cell lymphokine genes. Although these T cells are gradually increased with age 
and become predominant at senescent stage in normal mice, the generation is 
robustly accelerated during leukemia. In both conditions, their predominance is 
associated with the diminution of specific CD4+ T cell response. The results suggest 
that global T-cell immunodepression in senescence and leukemia is attributable to 






The elderly may show a substantial diminution in specific immune response against 
infection, a reduced efficacy for vaccination and a proinflammatory trait, being called 
immunosenescence (1, 2). In T-lineage cells, a most prominent effect of aging is thymic 
involution, resulting in the production and export of fewer T cells (3). Total numbers of 
peripheral T cells, however, are unaffected by aging in both humans and mice, owing in 
part to the homeostatic proliferation of memory phenotype (MP) T cells (4-6); 
consequently, T cell population shows a progressive shift from naïve to MP cells with 
age. Such a shift in T cell composition is considered to contribute significantly to 
immunosenescence. This may result in contraction of the T cell repertoire, leading to an 
increased incidence of poor responsiveness to new antigens (7). It is also recognized 
that CD4+ T cells in the elderly are qualitatively altered, including a number of defects 
in the TCR-mediated signaling pathways, reduced immunological synapse formation 
with antigen-presenting cells as well as cognate helper function for B cells, and altered 
lymphokine production patterns (8-11). These effects may be attributable primarily to 
the cellular changes of T cells rather than to the host environment (12). 
 The homeostatic maintenance of MP T cells for prolonged periods may 
involve multiple factors, including environmental antigens such as commensal bacteria, 
low-affinity self-ligands and homeostatic cytokines (4, 13, 14). The eventual fates of 
MP T cells, however, remain elusive. In most somatic tissue cells, programmed cell 




terminal differentiation with loss of proliferation capacity and limited life span. In 
myeloid-lineage cells, for instance, a bZIP family transcription factor C/EBPα plays a 
crucial role in controlling the homeostatic differentiation and the quiescence of 
terminally differentiated cells (15, 16). Expression of Cebpa, however, is repressed 
during T-lineage cell commitment from hematopoietic progenitors, and maturated T 
cells hardly express C/EBPα (17). Currently, it remains uncertain how the balance 
between proliferation and quiescence of MP T cell clones is controlled to maintain the 
homeostasis for prolonged periods. 
 In current study, we identify a bona fide age-dependent MP CD4+ T cell 
population defined by a constitutive expression of PD-1, which is only transiently 
induced on activation in regular T cells (18). The PD-1+ MP CD4+ T cells hardly 
proliferate in response to TCR stimulation but produce large amounts of a 
proinflammatory cytokine, osteopontin (OPN), at the cost of typical T-cell lymphokines. 
We suggest that the functional features of these cells are attributable in part to an 
unusual expression of C/EBPα. Besides in senescence, the generation of equivalent 
PD-1+ MP CD4+ T cells is robustly accelerated during leukemia. We provide evidence 
that the predominance of these unique T cells underlies global depression of T cell 





Identification of Age-dependent PD-1+ MP CD4+ T Cells with Defective 
TCR-mediated Proliferation 
We found that increasing proportions of splenic CD4+ T cells in normal B6 mice 
constitutively expressed PD-1 as they aged (Fig. 1A, upper). The PD-1+ CD4+ T cells 
were confined to a CD44high CD62Llow (MP) population, and the majority of them 
exhibited CD69 with little CD25 expression (Fig. 1A, lower). Purified CD4+ T cells 
from aged mice showed a significantly diminished TCR-mediated proliferation 
compared with those from young mice (Fig. 1B). Among the CD4+ T cells in aged mice, 
however, both naïve and PD-1– MP populations revealed the response comparable with 
those from young mice; in stark contrast, PD-1+ MP population showed no detectable 
proliferation, despite normal expression of αβTCR/CD3 (Fig. 1B). They showed no 
anexin V staining and thus were not dying cells in vivo (Fig. S1A). Costimulation with 
anti-CD28 antibody or IL-2 only marginally restored the proliferation (Fig. S1B). 
Furthermore, these T cells revealed negligible production of typical T-cell lymphokines 
in response to optimal TCR stimulation (Fig. S1C). PD-1+ MP CD4+ T cells showed a 
severely impaired repopulation capacity in Rag-2–/– mice (Fig. 1C, upper left). Because 
robust T cell expansion in Rag-2–/– recipients mostly represents the response to 
exogenous antigens such as commensal bacteria (13), these T cells are suggested to be 
defective in TCR-mediated proliferation in vivo as well. On the other hand, PD-1+ MP 
CD4+ T cells revealed a homeostatic expansion comparable with the PD-1- T cells in 




PD-1+ CD4+ T cells expressed IL-15R and/or IL-7R (Fig. 1C, right). Although PD-1+ 
cells represent a rare population in CD4+ T cells until 6 months of age, they are 
increased linearly throughout later stages, eventually becoming a predominant 
population at senescent stage (Fig. 1D). These T cells are found in most lymphoid 
tissues of aged mice, except for the peripheral blood (Fig. S1D), and the profile of 
TCR-Vβ chain usage is unchanged (Fig. S1E). We found that PD-1+ MP CD4+ T cells 
overexpressed Cd121b by DNA microarray analysis (see below) and confirmed that a 
portion of these T cells selectively expressed CD121b (Fig. S2A). PD-1–/– CD121b+ 
CD4+ T cells remained defective in TCR-mediated proliferation, suggesting that PD-1 
expression might be irrelevant for the effect (Fig. S2A). Stimulation of PD-1+ MP CD4+ 
T cells with PMA plus ionomycin bypassing TCR-stimulation failed to induce 
significant proliferation either, despite nearly normal ERK activation (Fig. S2B). Finally, 
PD-1+ MP CD4+ T cells completely depleted of CD25+ cells showed no TCR-mediated 
proliferation or inhibitory effect on the proliferation of normal CD4+ T cells (Fig. S2C). 
These results suggest that the defect in TCR-mediated proliferation may be intrinsic. 
 
Unique Genetic Signature and Potent OPN Production  
Given the age-dependency, we examined the possibility that PD-1+ MP CD4+ T cells 
might represent “senescent” T cells, with the use of senescence-associated 
β-galactosidase (SA-β-Gal) (19). Although CD4+ T cells from 2 month-old mice rarely 
showed SA-β-Gal staining, a significant proportion of MP, but not naïve, CD4+ T cells 




difference in the frequencies and the intensities between PD-1– and PD-1+ MP fractions 
(Fig. 2A). We then compared the global gene expression profiles by DNA microarray 
analysis (Table S1). We selected 37 genes from the data and compared their expression 
among naïve, PD-1– MP and PD-1+ MP fractions of CD4+ T cells by qRT-PCR (Fig. 2B). 
27 genes showed a markedly increased expression in a PD-1+ MP population, of which 
17 genes including Pdcd1 and Cd121b were overexpressed rather selectively, whereas 
the expression of 10 genes was decreased. PD-1+ MP CD4+ T cells were found only 
minimally in young mice (see Fig. 1A); however, the genetic signature of these cells 
highly coincided with those in aged mice (Fig. 2C), indicating that these T cells began 
to emerge early in life. At the top of the overexpressed genes was Spp1 encoding OPN 
(also called Eta-1). In agreement, PD-1+, but not PD-1–, MP CD4+ T cells spontaneously 
secreted significant amounts of OPN. Furthermore, these cells showed a prominently 
enhanced OPN secretion upon TCR stimulation (Fig. 2D, upper); this was associated 
with a robust increase in Spp1 transcripts, whereas the induction of Il-2, Ifn-γ and Il-4 
was significantly compromised (Fig. 2D, lower). These T cells additionally showed 
abundant transcripts of Sostdc-1, encoding a secreted antagonist of anti-inflammatory 
bone morphogenic factor (Fig. 2D).  
 
Unusual Expression of C/EBPα: A Role in the Unique Functional Features 
PD-1+ MP CD4+ T cells also revealed a remarkably altered expression of several 
transcription-related genes (see Fig. 2B). Immunoblotting analysis confirmed that these 




Cyclin D1 were hardly detectable (Fig. 3A). Because abundant expression of C/EBPα 
was particularly unexpected, we examined the effects of forced Cebpa expression in 
regular CD4+ T cells. Young CD4+ T cells were stimulated with anti-CD3 plus 
anti-CD28 antibodies and infected with Cebpa-containing MIG. Sorted GFP+ cells 
exhibited a largely comparable level of Cebpa transcripts with natural PD-1+ MP CD4+ 
T cells. The Cebpa-expressing CD4+ T cells revealed a significant repression of c-Myc, 
Cyclin D1, Il-2 and Il-4, with undetectable proliferation (Fig. 3B). On the contrary, 
these T cells revealed a robust activation of Spp1, while Satb1transcripts were 
unaffected (Fig. 3B). Although the detection of these proteins was unfeasible due to 
very limited cell numbers, the results suggest that the expression of C/EBPα may be 
responsible at least in part for the unique functional features of PD-1+ MP CD4+ T cells. 
 
Rapid and Robust Increase in PD-1+ MP CD4+ T Cells during Leukemia 
A global diminution of specific T cell response often develops in malignancy. To 
investigate the possible involvement of PD-1+ MP CD4+ T cells, we transplanted 
bcr/abl-induced leukemia cells (BA-1) into young B6 mice. Within 2 weeks as frank 
leukemia developed, the recipients revealed a marked increase in PD-1+ MP cells, 
preferentially in the CD4+ T cell population (Fig. 4A). The CD4+ T cells from leukemic 
mice showed a significantly diminished TCR-mediated proliferation; this was 
attributable to the defective response specifically of PD-1+ MP cells (Fig. 4B). Also, 
PD-1+ MP CD4+ T cells secreted by far greater amounts of OPN than PD-1– CD4+ T 




compromised (Fig. 4B). Similar results were obtained with an independent leukemia 
cell line. Because PD-L1 was hardly or only marginally expressed on these leukemia 
cells (Fig. S3A), it did not appear to be relevant for the effects. Spa-1–/– mice, which 
spontaneously developed various leukemia (20, 21) also showed a remarkable increase 
in PD-1+ MP CD4+ T cells after leukemia development (Fig. S3B, C). DNA microarray 
cluster and qRT-PCR analysis revealed highly coincided gene expression profiles 
between the PD-1+ MP CD4+ T cells in leukemic and normal aged mice (Fig. 4C). 
Kinetic analysis indicated that the proportions of PD-1+ MP CD4+ T cells were rapidly 
increased with the systemic spread of leukemia, and this was inversely correlated with 
the diminution of TCR-mediated CD4+ T cell proliferation (Fig. 4D).  
 
Emergence of PD-1+ CD4+ T MP cells is correlated with the clonal T-cell 
immunodepression in senescence and during leukemia. 
Tg mice of OVA-specific TCR (OT-II) at Rag2–/– background only barely developed MP 
T cells and accordingly few PD-1+ cells even at the age of 12 months (Fig. 5A, upper). 
The Rag2–/– OT-II cells revealed no diminution of, but rather an increase in, the 
OVA-specific proliferation compared with those from young mice (Fig. 5A, lower). 
Similarly, OT-II/Rag2–/– mice transplanted with BA-1 cells developed few PD-1+ MP 
CD4+ T cells with no diminution of OVA-specific T cell response, despite massive 
leukemia burden (Fig. 5A). In contrast, aged OT-II Tg mice at B6 background revealed 
a marked increase in PD-1+ MP CD4+ T cells including Vα2+ OT-II T cells (Fig. 5B, 




PD-1+ MP OT-II T cells revealed no detectable proliferation (Fig. 5B, lower). 
Transplantation of BA-1 cells in young OT-II/B6 mice caused even more prominent 
increase in PD-1+ MP OT-II T cells with a profound diminution of OVA-specific 
response (Fig. 5B). These results suggest at the clonal level that the generation of PD-1+ 
cells are concomitant with the development and expansion of MP CD4+ T cells, and that 





Naturally arising MP CD4+ T cells appear to be composed of heterogeneous populations, 
only a fraction of them being functional memory T cells (4). In current study, we have 
identified a distinct population within MP CD4+ T cells, which constitutively expresses 
PD-1 and partly CD121b and hardly proliferates nor produces typical T-cell 
lymphokines on TCR stimulation in vitro. PD-1+ MP CD4+ T cells show a severely 
impaired repopulation capacity in Rag2-/- mice, in which regular T cells exhibit a robust 
expansion in response to exogenous antigens, in particular commensal bacteria (13). 
The results suggest that these T cells are defective in antigen-specific response in vivo, 
although an additional possibility for the selective susceptibility to host NK cells as 
reported in certain CD4+ T cells (22) remains to be examined. In contrast, PD-1+ MP 
CD4+ T cells reveal a repopulation in irradiated B6 recipients comparably with PD-1- 
CD4+ T cells, suggesting that these cells respond to homeostatic cytokines. Thus, PD-1+ 
CD4+ T cells may represent a unique MP cell population, which are capable of 
homeostatic proliferation with little contribution to antigen-specific immune response 
based on the clonal expansion.  
Importantly, PD-1+ MP CD4+ T cells are steadily increased and accumulated 
with age in normal mice, becoming a predominant population at the senescent stage. 
Despite the age-dependent increase, analysis of SA-β-Gal expression argues against a 
possibility that these cells simply represent a classic cell-senescence; rather, the 
generation of these cells is suggested to be concomitant with the homeostatic 




appears to be associated with a unique genetic reprogramming. A most notable 
molecular feature is a strong expression of C/EBPα, which is normally expressed in 
nonlymphoid cells including myeloid cells (15). C/EBPα shows a potent 
antiproliferative effect either reversibly by interacting with Cdk inhibitors or 
irreversibly by repressing c-Myc (15, 23). In agreement, a forced expression of Cebpa in 
regular CD4+ T cells resulted in the loss of TCR-mediated proliferation capacity with 
the repression of c-Myc and Cyclin D1. Furthermore, it induced a prominent activation 
of Spp1 in concomitant with the inhibition of T-cell lymphokine gene activation, 
although the role of endogenous C/EBPα in natural PD-1+ MP CD4+ T cells remained to 
be proved. Interestingly, an artificial expression of Cebpa in thymic pre-T cells is 
reported to redirect their differentiation into myeloid cells with the repression of T 
cell-specific genes (17). In this aspect, it is noted that PD-1+ MP CD4+ T cells show a 
profoound repression of Satb1, a T cell-specific gene crucial for the development and 
function of T cells (24, 25). Satb1-/- T cells are also reported to show a enhanced Pdcd1 
expression (25); thus, the constitutive PD-1 expression may be due in part to Satb1 
repression. Unlike “exhausted” CD8+ T cells generated during chronic viral infection 
(26), current results suggest no relevant involvement of PD-1 in the defective 
proliferation of PD-1+ MP CD4+ T cells; however, other possible effects of PD-1 ligated 
by PD-L remain to be seen. 
PD-1+ MP CD4+ T cells with equivalent genetic and functional features to 
those in senescence are robustly increased during leukemia, suggesting that the 




accelerated in malignancy. In humans, leukemia patients often show a profound T cell 
immunodepression; a recent report indicates that the effects may be due in part to the 
changes in the gene expression of T cells upon interaction with leukemia cells (27). 
Intriguingly, OT-II Rag2-/- mice hardly developed this population, and the OA-specific 
responsiveness of these mice was well sustained with age and during leukemia. In 
contrast, OT-II B6 mice revealed a marked increase in the PD-1+ MP cell population 
similar to normal B6 mice in both conditions, resulting in a profound diminution of 
OVA-responsiveness. The reasons for the difference remain to be investigated; it may 
be possible that endogenous TCRs possibly expressed on B6 OT-II T cells are required 
for the development of PD-1+ MP cells. Nonetheless, the results indicate that the 
increase in PD-1+ MP cell proportion is directly associated with the progression of CD4+ 
T cell immunodepression in senescence and during leukemia. 
OPN is a potent proinflammatory cytokine produced by many cell types, 
including macrophages, dendritic cells and activated Th1 cells, and plays a significant 
role in inflammatory diseases (28, 29). Current results suggest that PD-1+ MP CD4+ T 
cells may also serve as a potent OPN producer, either spontaneously or inductively via 
TCR stimulation. The OPN production by these T cells seems to be controlled by 
C/EBPα, whereas that by Th1 cells is under the regulation by T-bet (30). Recently, T 
cell-intrinsic OPN is reported to function as an autocrine prosurvival factor for CD4+ T 
cells in vivo (31); thus, OPN may also contribute to the maintenance of PD-1+ MP CD4+ 
T cells in vivo. In addition, OPN may affect the growth and invasion of malignant cells, 




cells may contribute to a proinflammatory trait in the elderly as well as tumor 
progression. Manipulation of PD-1+ MP CD4+ T cells may provide a clue for restoring 





Materials and Methods 
Refer to SI Text for detailed materials and methods.  
Mice. The C57BL/6 (B6), B6 (CD45.1), Rag2–/–, SPA-1–/–, PD-1–/– and OT-II Tg mice, 
all at B6 background, were maintained in specific pathogen-free conditions at the 
Center of Laboratory Animals of Kyoto University under the University guidelines.  
 
Flow cytometry and cell culture. Multicolor flow cytometric analysis and cell sorting 
were performed with FACSCalibur and FACSAria (BD Biosciences). Cell proliferation 
was assessed by the incorporation of 3H-thymidine, and cytokines were measured with 
ELISA. 
 
Cell transfers. Purified CD4+ T cell subpopulations were injected intravenously into 
Rag2–/– or γ-ray (6 Gy)-irradiated B6 (CD45.1) mice (3 × 106 cells/head). BA-1 
leukemia cells were transplanted intravenously into normal B6 mice (1~5 × 106 
cells/head).  
 
Quantitative RT-PCR analysis. Real-time PCR was performed with LightCycler 
SYBR Green I marker kit on a LightCycler instrument (Roche).  
 
SA-β-Gal staining. T cells were plated on poly-L-lysine-coated cover slips, fixed with 
glutaraldehyde (0.5% in PBS), washed with Mg2+-containing PBS, and stained with 





Gene transduction. A Cebpa cDNA, provided by Dr. Iwama (Tsukuba University, 
Tsukuba, Japan), was subcloned into the retroviral plasmid (pMCs IRES GFP, pMIG) 
provided by Dr. Kitamura (University of Tokyo, Tokyo, Japan). Recombinant retrovirus 
was produced in Plat-E packaging cells.   
 
DNA microarray and clustering analysis 
Comprehensive DNA microarray analysis was performed with 3D-GeneTM (Toray 
Industries, Inc., Tokyo, Japan). Microarrays were scanned with the ScanArray Lite 
Scanner (Perkin-Elmer) and analyzed with the Cluster 3.0. 
 
Statistical analysis 





We thank T. Sudo and H. Akiyama (Toray New Frontiers Research Laboratories) for 
assistance with the DNA microarray analysis; K. Aoki and A. Nabetani for assistance 
with the data analysis of SA-β-Gal staining; A. Iwama and T. Kitamura for provision of 
plasmids. This work was supported by the grants from Ministry of Education, Culture, 




K.S. principally contributed to general experiments; Y.N. performed the experiments on 
leukemia model; H.M. contributed to the plasmid preparations and discussions; Y.H. 
contributed to the SA-β-Gal staining and discussions; and N.M. provided overall design 
of the work and wrote a manuscript. 
 
COMPETING INTERESTS STATEMENT 





1. Linton PJ, Dorshkind K (2004) Age-related changes in lymphocyte development 
and function. Nat Immunol 5: 133-139. 
2. Globerson A, Effros RB (2000) Ageing of lymphocytes and lymphocytes in the 
aged. Immunol Today 21: 515-521. 
3. Haynes BF, et al. (2000) The role of the thymus in immune reconstitution in 
aging, bone marrow transplantation, and HIV-1 infection. Annu Rev Immunol 
18: 529-560. 
4. Surh CD, Boyman O, Purton JF, Sprent J (2006) Homeostasis of memory T cells. 
Immunol Rev 211: 154-163. 
5. Seddon B, Tomlinson P, Zamoyska R (2003) Interleukin 7 and T cell receptor 
signals regulate homeostasis of CD4 memory cells. Nat Immunol 4: 680-686. 
6. Kondrack RM, et al. (2003) Interleukin 7 regulates the survival and generation 
of memory CD4 cells. J Exp Med 198: 1797-1806. 
7. Schwab R, et al. (1997) Expanded CD4+ and CD8+ T cell clones in elderly 
humans. J Immunol 158: 4493-4499. 
8. Miller RA, Garcia G, Kirk CJ, Witkowski JM (1997) Early activation defects in 
T lymphocytes from aged mice. Immunol Rev 160: 79-90. 
9. Garcia GG, Miller RA (2001) Single-cell analyses reveal two defects in 
peptide-specific activation of naive T cells from aged mice. J Immunol 166: 
3151-3157. 
10. Eaton SM, et al. (2004) Age-related defects in CD4 T cell cognate helper 
function lead to reductions in humoral responses. J Exp Med 200: 1613-1622. 
11. Dayan M, et al. (2000) Effect of aging on cytokine production in normal and 
experimental systemic lupus erythematosus-afflicted mice. Exp Gerontol 35: 
225-236. 
12. Haynes L, et al. (2005) Newly generated CD4 T cells in aged animals do not 
exhibit age-related defects in response to antigen. J Exp Med 201: 845-851. 
13.  Kieper WC, et al. (2005) Recent immune status determines the source of 
antigens that drive homeostatic T cell expansion. J Immunol 174: 3158-3163. 
14. Lenz DC, et al. (2004) IL-7 regulates basal homeostatic proliferation of antiviral 




15. Johnson PF (2005) Molecular stop signs: regulation of cell-cycle arrest by 
C/EBP transcription factors. J Cell Sci 118: 2545-2555. 
16. Zhang P, et al. (2004) Enhancement of hematopoietic stem cell repopulating 
capacity and self-renewal in the absence of the transcription factor C/EBP alpha. 
Immunity 21: 853-863 
17. Laiosa CV, et al. (2006) Reprogramming of committed T cell progenitors to 
macrophages and dendritic cells by C/EBP alpha and PU.1 transcription factors. 
Immunity 25: 731-744. 
18. Okazaki T, Honjo T (2006) The PD-1-PD-L pathway in immunological tolerance. 
Trends Immunol 27:195-201. 
19. Dimri GP, et al. (1995) A biomarker that identifies senescent human cells in 
culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367. 
20. Ishida D, et al. (2003) Myeloproliferative stem cell disorders by deregulated 
Rap1 activation in SPA-1-deficient mice. Cancer Cell  4: 55-65. 
21. Ishida D, et al. (2003) Antigen-driven T cell anergy and defective memory T cell 
response via deregulated Rap1 activation in SPA-1-deficient mice. Proc Natl 
Acad Sci USA 100: 10919-10924. 
22. Lu L, et al. (2007) Regulation of activated CD4+ T cells by NK cells via the 
Qa-1-NKG2A inhibitory pathway. Immunity 26: 593-604. 
23. Iakova P, Awad SS, Timchenko NA (2003) Aging reduces proliferative 
capacities of liver by switching pathways of C/EBPalpha growth arrest. Cell 
113: 495-506. 
24. Cai S, Lee CC, Kohwi-Shigematsu T (2006) SATB1 packages densely looped, 
transcriptionally active chromatin for coordinated expression of cytokine genes. 
Nat Genet 38: 1278-1288. 
25. Alvarez JD, et al. (2000) The MAR-binding protein SATB1 orchestrates 
temporal and spatial expression of multiple genes during T-cell development. 
Genes Dev 14: 521-535. 
26. Barber DL, et al. (2006) Restoring function in exhausted CD8 T cells during 
chronic viral infection. Nature 439: 682-687. 
27. Gorgun G, et al. (2005) Chronic lymphocytic leukemia cells induce changes in 
gene expression of CD4 and CD8 T cells. J Clin Invest 115: 1797-1805. 




stress responses. Cytokine Growth Factor Rev 19: 333-345. 
29. Jansson M, et al. (2002) Cutting edge: Attenuated experimental autoimmune 
encephalomyelitis in eta-1/osteopontin-deficient mice. J Immunol 168: 
2096-2099. 
30. Shinohara ML, et al. (2005) T-bet-dependent expression of osteopontin 
contributes to T cell polarization. Proc Natl Acad Sci USA 102: 17101-17106. 
31. Hur EM, et al. (2007) Osteopontin-induced relapse and progression of 
autoimmune brain disease through enhanced survival of activated T cells. Nat 
Immunol 8: 74-83. 
32. El-Tanani MK, et al. (2006) The regulation and role of osteopontin in malignant 
transformation and cancer. Cytokine Growth Factor Rev 17: 463-474. 
33. McAllister SS, et al. (2008) Systemic endocrine instigation of indolent tumor 





Figure Legends  
Fig. 1. Age-dependent increase in PD-1+ MP CD4+ T cells with defective TCR-mediated 
proliferation. (A) Spleen cells from normal B6 mice at the various ages were three-color 
analyzed with the indicated antibodies. (B) CD4+ T cells from 2-month-old (open 
column) and 16-month-old (solid column) mice were cultured in the presence of 
anti-CD3 antibody for 3 days and pulsed with 3H-TdR (left panel). CD4+ T cells from 
16-month-old mice were separated into CD44low (light grey column), PD-1– CD44high 
(dark gray column) and PD-1+ CD44high (solid column) populations and cultured 
similarly (middle panel). *, P < 0.05; **, P < 0.01. The latter two populations were 
analyzed for the expression TCRβ and CD3 (right panel). (C) Sorted PD-1– and PD-1+ 
CD44high CD4+ T cells from aged mice were transferred into Rag2–/– (upper left) or 
γ-ray-irradiated CD45.1 B6 (lower left) mice intravenously, and 6 days later the donor T 
cells (boxed) in the pooled lymphoid tissues were assessed. Percent donor cells of total 
and CD4+ T cells in Rag2-/- and irradiated B6 recipients are indicated, respectively. 
Similar results were obtained in 3 recipients. T cells from normal aged B6 mice were 
three-color analyzed with the indicated antibodies (right). (D) The proportions of total 
CD44high (dotted lines), PD-1– CD44high (open circles) and PD-1+ CD44high (closed 
circles) T cells in CD4+ T cell population at various ages are plotted.  
 
Fig. 2. PD-1+ MP CD4+ T cells show a distinctive genetic signature. (A) CD4+ T cells 
from 2-month-old B6 mice as well as sorted CD44low (I), PD-1– CD44high (II) and PD-1+ 




SA-β-Gal. The arbitrary signal units of about 100 cells in each group are plotted. (B) 
Sorted CD44low (I), PD-1– CD44high (II) and PD-1+ CD44high (III) CD4+ T cell populations 
from aged mice were analyzed for the expression of 43 genes with qRT-PCR. Relative 
transcripts in the three populations are indicated. (C) PD-1– and PD-1+ CD44high CD4+ T 
cells sorted from 2- and 12-month-old mice were analyzed for the transcripts of 16 
genes with qRT-PCR. The ratios of transcripts (PD-1+/PD-1– CD44high CD4+ T cells) for 
each gene in the 2 groups are plotted against each other. (D) Sorted PD-1– (open 
columns) and PD-1+ (solid columns) CD44high CD4+ T cells from aged mice were 
cultured with or without anti-CD3 plus anti-CD28 antibodies. OPN in the culture 
supernatants was assessed on days 1 and 3 with ELISA (upper). Aliquots of the cells 
were harvested on day 1, and the transcripts of the indicated genes were assessed with 
qRT-PCR (lower). N.D.; not detectable. 
 
Fig. 3. Expression of Cebpa in regular CD4+ T cells recapitulates the functional features 
of PD-1+ MP CD4+ T cells. (A) Sorted PD-1– and PD-1+ CD44high CD4+ T cells from 
aged mice were immunoblotted with the indicated antibodies. (B) Sorted CD4+ T cells 
from young mice were cultured with anti-CD3 plus anti-CD28 antibodies and infected 
with an empty (open columns) or Cebpa-containing (solid columns) retrovirus (MIG) 
on day 1. GFP+ T cells were sorted on day 3 and assessed for transcripts of the indicated 
genes with qRT-PCR (upper). The cells were cultured in the presence of IL-2 for 2 more 





Fig. 4. Senescence-related PD-1+ MP CD4+ T cells are generated robustly during 
leukemia. (A) Young B6 mice were inoculated intravenously with BA-1 leukemia cells, 
and the cells of BM, spleen and blood from 2-week posttransplant mice were 
three-color analyzed with the indicated antibodies. Circles indicate the leukemia cells. 
(B) CD4+ T cells from pre- (light gray column) and post-transplant (dark gray column) 
mice were cultured with anti-CD3 antibody for 3 days to assess DNA synthesis (upper 
left). The CD4+ T cells from leukemia-bearing mice were separated into PD-1– (open 
column) and PD-1+ (solid columns) CD44high populations and cultured similarly (upper 
middle). The indicated cytokines in the culture supernatants were assessed with ELISA 
(upper right and lower). *, P < 0.01, *, P < 0.05. (C) DNA microarray data of PD-1– and 
PD-1+ CD44high CD4+ T cells from normal aged and BA-1-bearing young mice were 
subjected to the cluster analysis with the combinations of PD-1+ [aged]/PD-1– [aged] (I), 
PD-1+ [leukemic]/PD-1– [aged] (II) and PD-1+ [leukemic]/PD-1– [leukemic] (III) (upper 
panel). The ratios of transcripts (PD-1+/PD-1- populations) of 16 genes in the two groups 
are plotted against each other (lower). (D) The proportions of leukemia cells in the 
blood (solid circles), PD-1+ CD44high cells in the splenic CD4+ T cells (open squares) as 
well as the TCR-mediated proliferation of CD4+ T cells (open circles) were assessed at 
various days after the inoculation with BA-1 cells. The means of 3 mice are shown. 
 
Fig. 5. Emergence of PD-1+ CD4+ T MP cells is correlated with the clonal T-cell 
immunodepression in senescence and during leukemia. (A) Spleen cells from normal 




columns) OT-II/Rag2–/–mice were three-color analyzed with the indicated antibodies. 
The CD4+ cells were sorted from each group and cultured in the presence of irradiated 
B6 spleen cells with or without OVA for 3 days. *, P < 0.01. (B) Identical experiments 
were performed in OT-II/B6 mice, except that PD-1– (light gray columns) and PD-1+ 
(dark gray columns) CD44high CD4+ T cells were examined separately in aged mice. *, P 







SI Materials and Methods 
Cell lines. BA-1 (B220+ pro-B cell leukemia) cell line was established from the bone 
marrow of SPA-1–/– mice by bcr-abl (GFP) transduction. Wo-1 (pro-T cell leukemia) 
cell line was established from the T-cell leukemia developed in the recipients of 
C3G-transfected Spa-1-/- bone marrow cells. These leukemia cells in blood were 
monitored by flow cytometry for GFP. 
 
Flow cytometry. The following antibodies were used: antibodies to CD3ε, CD4, CD8, 
CD25, CD44, CD45.1, CD45.2, CD62L, CD69, B220, TCR-Vβs, Foxp3, IL-7Rα, 
IL-15Rβ, anexin V (eBioscience), CD121b and TCRβ (BD Pharmingen). 
 
Quantitative RT-PCR analysis. Total RNA was extracted from the purified CD4+ T 
cell subpopulations with a NucleoSpin RNA kit (Macherey-Nagel) followed by cDNA 
synthesis with SuperScript III (Invitrogen). The primer pairs are listed in Table S2. The 
transcripts of each gene were normalized to those of cyclophilin. 
 
Immunoblotting. Cells were lysed with ice-cold RIPA lysis buffer containing protease 
inhibitors, and the extracts were subjected to immunoblotting.  Antibodies included 
β-actin, Bcl6, C/EBPα, ERK2, pERK1/2, cFos, IRF8, OcaB, Satb1, VDR (Santa Cruz), 
c-Jun, c-Myc and Cyclin D1 (Cell Signaling Technology). 
  
SA-β-Gal staining. The microscopic images of SA-β-Gal staining were stored in Tiff 
files, and blue color signal per cell was quantified with the use of MetaMorph software 
(Molecular Devices). 
 
DNA microarray and clustering analysis. ; PMT levels were adjusted to achieve 
0.1%-0.5% pixel saturation; and each tiff image was analyzed with GenePix Pro 6.0 
(Molecular Devices). Data were filtered to remove low-confidence measurements and 
globally normalized per array such that the median log2 (Cy3/Cy5 fluorescence ratio) 
was zero after normalization. 
Legends for Supporting Figures 
Fig. S1. Proliferation capacity, organ distribution and TCRβ repertoire of PD-1+ MP 
CD4+ T cells. (A) Spleen cells from 12 month old B6 mice were 3-color analyzed with 
the indicated antibodies. (B) PD-1- (open columns) and PD-1+ (closed columns) 
CD44high CD4+ T cells sorted from 12-month old B6 mice were cultured in the presence 
of anti-CD3 antibody (5 µg/ml) with or without anti-CD28 antibody (2.5 µg/ml) or IL-2 
(100 U/ml) for 3 days and pulsed with 3H-TdR. **; P<0.01. (C) PD-1– (open columns) 
and PD-1+ (solid columns) CD44high CD4+ T cells sorted from aged mice were cultured 
in the presence of anti-CD3 plus anti-CD28 antibodies for 3 days, and the indicated 
lymphokines were assessed with ELISA. N.D.; not detectable.  (D) Cells from the 
blood and indicated lymphoid tissues of 2- and 12-month old B6 mice were three-color 
analyzed with anti-CD3, anti-PD-1, and anti-CD4 antibodies. The profiles in a CD3+ 
gate are indicated. (E) PD-1- (open columns) and PD-1+ (closed columns) CD44high 
CD4+ T cells sorted from 12-month old B6 mice were analyzed with a set of anti-TCRβ 
chain antibodies with FACSCaliber.  
 
Fig. S2. PD-1+ MP CD4+ T cells are intrinsically defective for TCR-mediated 
proliferation. (A) Spleen cells from B6 and PD-1–/– mice at the age of 12 months were 
three-color analyzed with the indicated antibodies (left). PD-1– CD121b– (a, open 
column), PD-1+ CD121b– (b, gray column) and CD121b+ (c, solid column) CD4+ T cells 
were sorted and cultured in the presence of anti-CD3 antibody with or without IL-2 for 
3 days (right). *, P < 0.01. (B) PD-1– (open column) and PD-1+ (closed column) CD44+ 
CD4+ T cells from aged B6 mice were cultured in the presence of PMA plus ionomycin 
for 10 min to detect ERK activation and for 3 days to assess the proliferation. Relative 
p-ERK/ERK ratio was assessed by a densitometry. **, P < 0.01. (C) PD-1– (open 
circles) and PD-1+ (closed circles) CD25– CD4+ T cells sorted from aged mice were 
cocultured with CD4+ T cells from young mice at various ratios in the presence of 
anti-CD3 plus and-CD28 antibodies for 3 days.  
 
Fig. S3. PD-1+ MP CD4+ T cells are increased as Spa-1-/- mice spontaneously develop 
frank leukemia. (A) Expression of PD-L1 was analyzed in the leukemia cell lines (BA-1 
pro-B cell and Wo-1 pro-T cell leukemia), both of which are capable of inducing the 
rapid generation of PD-1+ MP CD4+ T cells in vivo. (B) Spleen cells from Spa-1-/- mice 
with frank leukemia (B-ALL and CML) and from age-matched (12 month-old) control 
B6 mice were 3-color analyzed with the indicated antibodies. Circles indicate the 
leukemia cells. (C) The proportions of PD-1+ MP CD4+ T cells in the spleen cells from 
Spa-1-/- mice at various ages are plotted. Open circles indicate the mice with no 





Table S1. DNA microarray analysis 
  Normal aged B6 
[Overexpressed genes] MP CD4+ T cells  
  PD-1(-) PD-1 (+) Ratio 
Transcription factors    
Batf basic leucine zipper transcription factor, ATF-like  883  2824  3.2  
Nfil3 nuclear factor, interleukin 3, regulated  237  740  3.1  
Zdhhc2 zinc finger, DHHC domain containing 2  145  388  2.7  
Hif1a hypoxia inducible factor 1, alpha subunit  292  1003  3.4  
Plagl1 pleiomorphic adenoma gene-like 1  143  826  5.8  
Tox thymocyte selection-associated HMG box gene  684  2017  3.0  
Cebpa 
CCAAT/enhancer binding protein (C/EBP), alpha 
(Cebpa)  183.4  970.5  4.8  
Pou2af1 POU domain, class 2, associating factor 1 (Pou2af1)  265.8  948.4  3.2  
Bcl6 B-cell leukemia/lymphoma 6 (Bcl6) 1147.3  3914.7  3.1  
Egr2 early growth response 2 (Egr2) 765.1  1622.8  1.9  
Vdr vitamin D receptor (Vdr), mRNA 183.8  893.1  4.4  
Membrane proteins    
Pdcd1 programmed cell death 1  107  646  6.0  
Cacna1d calcium channel, voltage-dependent, L type, alpha 1D  40  161  4.0  
Cd121b interleukin 1 receptor, type II  79  584  7.4  
Ptger2 prostaglandin E receptor 2 (subtype EP2)  63  241  3.8  
Tnfsf8 tumor necrosis factor (ligand) superfamily, member 8  333  959  2.9  
Cxcr4 chemokine (C-X-C motif) receptor 4  168  874  5.2  
Cd200 Cd200 antigen 204  678  3.3  
Cd83 CD83 antigen  310  1491  4.8  
Blr1 Burkitt lymphoma receptor 1  529  1757  3.3  
Cd81 CD 81 antigen (Cd81) 3426.2  11450.9  3.0  
Cytokines/secreted proteins    
Sostdc1 sclerostin domain containing 1  397  5375  13.5  
Ccl3 
chemokine (C-C motif) ligand 3 
[Source:MarkerSymbol;Acc:MGI:98260] 107  646  6.0  
Ccl4 chemokine (C-C motif) ligand 4  203  926  4.6  
Il4 interleukin 4  176  421  2.4  
Il21 interleukin 21 173  1017  5.9  
Stfa1 stefin A3  19  229  12.3  
Spp1 pogo transposable element with ZNF domain  96  1418  14.7  
Esm1 endothelial cell-specific molecule 1  179  530  3.0  
Cytoplasmic proteins    
Cdkn2b 
cyclin-dependent kinase inhibitor 2B (p15, inhibits 
CDK4)  75  294  3.9  
Sccpdh saccharopine dehydrogenase (putative)  92  461  5.0  
Rgs16 regulator of G-protein signaling 16  97  492  5.1  
Srxn1 sulfiredoxin 1 homolog (S. cerevisiae)  135  361  2.7  
Pfn2 profilin 2 66  241  3.7  
Stk39 
serine/threonine kinase 39, STE20/SPS1 homolog 
(yeast)  502  1154  2.3  
Cxxc5 ring finger protein 128  103  266  2.6  
Stx11 syntaxin 11  325  1241  3.8  
Tbc1d4 TBC1 domain family, member 4  551  1696  3.1  
     
[Underexpresssed genes]    
     
Transcription factors    
Cbfa2t3h core-binding factor, runt domain, alpha subunit 2 385  54  0.1  
Jun Jun oncogene  466  114  0.2  
Irf8 interferon regulatory factor 8  607  73  0.1  
Satb1 special AT-rich sequence binding protein 1  912  83  0.1  
Cd74 Mus musculus CD74 antigen  8101.8  2714.8  0.3  
Membrane proteins    
Cd226 CD226 antigen (Cd226) 309.4  18.5  0.1  
Cd74 Mus musculus CD74 antigen  8101.8  2714.8  0.3  
Cd8b1 CD8 antigen, beta chain 1  451  164  0.4  
H2-Ob histocompatibility 2, O region beta locus  686  332  0.5  
Sell selectin, lymphocyte  695  163  0.2  
Il7r interleukin 7 receptor  1039  470  0.5  
Ccr7 chemokine (C-C motif) receptor 7  238  95  0.4  
Trat1 T cell receptor associated transmembrane adaptor 1  1144  309  0.3  
Cd72 CD72 antigen  477  130  0.3  
Ccr2 chemokine (C-C motif) receptor 2  660  188  0.3  
Klrd1 killer cell lectin-like receptor, subfamily D, member 1  235  43  0.2  
H2-DMb2 histocompatibility 2, class II, locus Mb1  560  90  0.2  
Cd7 CD7 antigen  334  133  0.4  
Ifitm1 interferon induced transmembrane protein 1  303  44  0.1  
Cd8a CD8 antigen, alpha chain  167  52  0.3  
Klrc1 killer cell lectin-like receptor subfamily C, member 1  281  33  0.1  
Lair1 leukocyte-associated Ig-like receptor 1  142    
Cd74 CD74 antigen  13810  2083  0.2  
Fcer1g Fc receptor, IgE, high affinity I, gamma polypeptide 968  70  0.1  
Amica1 adhesion molecule, interacts with CXADR antigen 1  474  36  0.1  
Ly6d lymphocyte antigen 6 complex, locus D  412  54  0.1  
Ly6c1 lymphocyte antigen 6 complex, locus C1  1105  24  0.0  
H2-Eb1 
histocompatibility 2, class II antigen E beta 
[Source:MarkerSymbol;Acc:MGI:95901] 8877  453  0.1  
Siglech sialic acid binding Ig-like lectin H 633  17  0.0  
[Source:MarkerSymbol;Acc:MGI:2443256] 
Mgl1 macrophage galactose N-acetyl-galactosamine specific  154    
H2-Ab1 histocompatibility 2, class II antigen A, beta 1  6391  268  0.0  
Igl-V1 immunoglobulin lambda chain, variable 1  258    
Ly86 lymphocyte antigen 86  495  16  0.0  
H2-Aa histocompatibility 2, class II antigen E alpha  14275  391  0.0  
Cytokines/secreted proteins    
Cfp complement factor properdin  428  107  0.2  
Il1b interleukin 1 beta  467  27  0.1  
Cytoplasmic proteins    
Hck hemopoietic cell kinase  742  174  0.2  
Txk TXK tyrosine kinase  1112  226  0.2  
Prkcn protein kinase C, nu  169  17  0.1  
Ncf1 neutrophil cytosolic factor 1  366  38  0.1  
Ctsh cathepsin H  583  35  0.1  
Pld4 phospholipase D family, member 4  667    
Unc93b1 unc-93 homolog B1 (C. elegans)  425  163  0.4  
Nedd4 neural precursor cell expressed,  395  111  0.3  
Rnf130 ring finger protein 130  316  69  0.2  
Plac8 placenta-specific 8  1943  58  0.0  
Tyrobp TYRO protein tyrosine kinase binding protein  2125  65  0.0  
Pld4 phospholipase D family, member 4  667    
Cell cycle-related proteins    
Ccnd1 cyclin D1 (Ccnd1) 1818.8  99.0  0.1  
 
Table S2. Primer sequences for quantitative PCR 
genes sense antisense 
Angptl2 CTGGACAGGGACCATGATGT GGAGTGAGCACAGGCGTTAT 
Cbfa2t3h CTGACTGTCATCAACCAGCAA TTACAGCCACTGCACGTCTC 
Ccnd1 GAACAAGCTCAAGTGGAACC CTTCAATCTGTTCCTGGCAG 
Ccr8 AGAAGAAAGGCTCGCTCAGA GGCTCCATCGTGTAATCCAT 
Cebpa TGAGAAAAATGAAGGGTGCAG CGGGATCTCAGCTTCCTGT 
c-myc CGAAACTCTGGTGCATAAACTG GAACCGTTCTCCTTAGCTCTCA 
Cxcr6 AAGCTACTGGGCTTCTCTTCTG CCCATCGTACAGAGCTGACTC 
Cyclophilin GACGAAGGTAGCCAGTCACAAG AATCAGGCCTGTGGAATGTGAG 
Ifng ATCTGGAGGAACTGGCAAAA TTCAAGACTTCAAAGAGTCTGAGG 
Il1r2 CCCATCCCTGTGATCATTTC GCACGGGACTATCAGTCTTGA 
Il2 GCTGTTGATGGACCTACAGGA TTCAATTCTGTGGCCTGCTT 
Il21 TCATCATTGACCTCGTGGCCC ATCGTACTTCTCCACTTGCAATCCC 
Il4 GAGAGATCATCGGCATTTTGA TCTGTGGTGTTCTTCGTTGC 
Irf8 CCAACCAGTTCATCCGAGA GAATGAGTTTGGAGCGCAAG 
Klf2 CTAAAGGCGCATCTGCGTA TAGTGGCGGGTAAGCTCGT 
Ly6c TCTTGTGGCCCTACTGTGTG GCAATGCAGAATCCATCAGA 
Pdcd1 CTACCTCTGTGGGGCCATC GAGGTCTCCAGGATTCTCTCTGT 
Pou2af1 CCTCCTCGGTGTTGACCTAT CGGGTGTAGCAGTGCTTCTT 
Satb1 ACTGAAACGAGCCGGAATC CGGAGGATTTCAGAAAGCAA 
Slc24a3 GCCTCATTGTAGCCAGACAAG ACGTTGCTCCCAATGGAAT 
Soscdc1 AACAGCACCCTGAATCAAGC CAGCCCACTTGAACTCGAC 
Spp1 CCCGGTGAAAGTGACTGATT TTCTTCAGAGGACACAGCATTC 
Vdr CACCTGGCTGATCTTGTCAGT CTGGTCATCAGAGGTGAGGTC 
Bace2 CCTGAGAGATGAGAATGCCAGT ATCATGGGCTGAATGTAGAGC 
Bhlhb2 TGAAGCACGTGAAAGCATTG TTTCTTCCCGACAAATCACC 
Npas4 AGGGTTTGCTGATGAGTTGC CCCCTCCACTTCCATCTTC 
Grail GTAACCCGCACACCAATTTC GTGAGACATGGGGATGACCT 
Apoe GACCCTGGAGGCTAAGGACT AGAGCCTTCATCTTCGCAAT 
Tnfsf8 GAGGATCTCTTCTGTACCCTGAAA TTGGTATTGTTGAGATGCTTTGA 
Cd121b CCCATCCCTGTGATCATTTC GCACGGGACTATCAGTCTTGA 
Ecel1 GCCCAACAAGAATCAAATGG CCCCCGTAGTTCAGAGACTG 
Bir1 GGAGGGTACCACTCACATGG TTGCCTGCTAACTTCCCCTA 
Nrbp2 CTGAGTGACCCCAACATGC CGGTGGAAGAGGAGGTTGT 
Bcl6 TTCCGCTACAAGGGCAAC CAGCGATAGGGTTTCTCACC 
Cd83 TGGTTCTGAAGGTGACAGGA CAACCAGAGAGAAGAGCAACAC 
Egr2 GTGCCAGCTGCTATCCAGAAG GGCTGTGGTTGAAGCTGGAG 
Nfil3 AGGCCGATGAGGGTGTAGT GCCCTTAGGGACCTGTTGTT 
Batf AGCTTCAGCCGCTCTCCT GCAGCGATGCGATTCTTC 
Scin CACAGTTCTCCGCAGATGG CACTGTTCTCTACACGCCAGA 
Rgs16 GGCCAGTAAGCATAACAAAGAGA TCAGCAGCAAATCGAAAGAC 
Cd200 CTCCACCTACAGCCTGATTTG CCTGGGTCACCACTTCCA 
Hif1a GCACTAGACAAAGTTCACCTGAGA CGCTATCCACATCAAAGCAA 
Nr4a2 TCAGAGCCCACGTCGATT TAGTCAGGGTTTGCCTGGAA 
Tnfrsf9 TGTGACTCCAGAGGGAGGAC AGCAGCAAAGCCGATGTC 
Cd81 CCTGGAACTGGGAAACAAAC GCTCCCACAGCAATGAGAAT 
Ly6d TCTGCTCGTCCTCCTTGTCT GTGCACACGTGACATCGAA 
Trat AGGAAGTGGCTGCACCTG CCAGTGAGGCATAGCACATC 
Ly86 ATTCTGAACTACTCCTATCCCCTTT GGCCGGCATAGTATATCTGTTCT 
 
